sk&f-38393 has been researched along with 4-butyrolactone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giambalvo, CT | 1 |
| Nomura, Y; Sekihara, S; Suda, H; Watanabe, H | 1 |
| Ahlenius, S; Ericson, E; Florvall, L; Hillegaart, V; Jiménez, P; Wijkström, A | 1 |
3 other study(ies) available for sk&f-38393 and 4-butyrolactone
| Article | Year |
|---|---|
Protein kinase C and dopamine release--III. Effect of dopamine depleting drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 4-Butyrolactone; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Calcium-Calmodulin-Dependent Protein Kinases; Dopamine; Dopamine Agents; Elongation Factor 2 Kinase; Ergolines; Male; Methyltyrosines; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Quinpirole; Rats; Sulpiride | 1989 |
D-1 type of dopamine autoreceptors are not involved in the regulation of dopamine synthesis in the striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 4-Butyrolactone; Animals; Apomorphine; Benzazepines; Corpus Striatum; Dopamine; Male; Mice; Receptors, Dopamine | 1987 |
In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D(2) receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 4-Butyrolactone; alpha-Methyltyrosine; Animals; Brain Chemistry; Catecholamines; Dihydroxyphenylalanine; Dopamine; Dopamine Agonists; Ethylamines; Fluorobenzenes; GABA Modulators; Male; Monoamine Oxidase Inhibitors; Motor Activity; Pargyline; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reserpine; Sympatholytics | 2000 |